Appeals Panel Clears Rite Aid of Fraud Charges
- Share via
Rite Aid Corp. isn’t required by law to disclose that it charged uninsured customers more for prescription drugs than those with insurance, a federal appeals panel ruled. Several people without prescription drug insurance sued Rite Aid in federal court in Alabama last year, contending that the drugstore operator violated a U.S. racketeering statute by selling medicines to insured patients at lower prices, and not disclosing that policy. A U.S. District Court judge dismissed the complaint, saying Rite Aid’s failure to disclose the policy was not fraudulent. An opinion released by a three-judge U.S. 11th Circuit Court of Appeals panel in Atlanta affirmed that decision. Shares of Camp Hill, Pa.-based Rite Aid fell 6 cents to close at $2.88 on the NYSE.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.